Comparison
6q Terminal Deletion Syndrome C4304514 vs 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
Clinical comparison between 6Q Terminal Deletion Syndrome and 2 Methylacetoacetyl Coa Thiolase Deficiency for differential diagnosis and treatment planning.
6q Terminal Deletion Syndrome C4304514
A chromosomal disorder involving deletion of genetic material at the end of chromosome 6, leading to developmental delays and variable physical features.
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
A rare metabolic disorder affecting how the body breaks down certain amino acids. It can cause buildup of harmful acids. Treatment focuses on diet and managing metabolic crises.
6 comparison axes
Onset
6q Terminal Deletion Syndrome C4304514
0-0
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
0-5
Onset patterns differ
Severity
6q Terminal Deletion Syndrome C4304514
severe
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
moderate
Different severity levels
Chronic
6q Terminal Deletion Syndrome C4304514
Chronic
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
Chronic
Differing course
Communicable
6q Terminal Deletion Syndrome C4304514
No
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
No
Different transmission
Body System
6q Terminal Deletion Syndrome C4304514
congenital
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
metabolic
Same/different system
Category
6q Terminal Deletion Syndrome C4304514
genetic
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
metabolic
Different category
Bottom line
6q-terminal-deletion-syndrome-C4304514 and 2-methylacetoacetyl-coa-thiolase-deficiency-C2930874 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q Terminal Deletion Syndrome C4304514 | 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Delays and variable congenital features may be evident from birth. | Development may be normal between episodes, though crises can affect the nervous system. | Moderate |
| Metabolic decompensation | Not a defining feature based on the supplied description. | Episodes of harmful acid buildup may occur, especially with illness or fasting. | High |
| Physical findings | Physical features can vary and are not uniform. | No characteristic physical appearance is established by the supplied data. | Low |
When to favor each condition
Choose 6q Terminal Deletion Syndrome C4304514 when
Congenital developmental concerns
A chromosomal cause is more relevant when features are present from birth.
Moderate
Variable dysmorphic or structural findings
The deletion syndrome is defined by missing terminal chromosome 6 material, not a metabolic pathway defect.
High
No episodic acidotic illness
Absence of metabolic crises does not exclude either condition, but favors considering a chromosomal evaluation.
Low
Choose 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 when
Infancy or early-childhood metabolic crisis
The metabolic disorder may present between birth and age 5 with acid accumulation.
Moderate
Illness or fasting triggers deterioration
Triggers suggest impaired amino-acid or ketone metabolism rather than a chromosomal deletion.
Moderate
Abnormal organic-acid or acylcarnitine pattern
Such results support targeted metabolic and genetic evaluation; they are not themselves a diagnosis.
High
How key tests differ
| Test | 6q Terminal Deletion Syndrome C4304514 | 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify terminal deletion of chromosome 6. | Expected to be normal if no separate chromosomal condition exists. | A detected deletion supports the chromosomal diagnosis; clinician correlation is required. |
| Urine organic acids and blood acylcarnitines | No characteristic pattern is established. | May show metabolites suggesting the enzyme deficiency, without a universal cutoff supplied here. | Abnormal results require confirmatory testing and are not definitive alone. |
| ACAT1 or enzyme testing | Not the primary diagnostic test. | Pathogenic ACAT1 variants or reduced enzyme activity can support the diagnosis. | Interpretation depends on laboratory methods and clinical context. |
Prognosis comparison
6q Terminal Deletion Syndrome C4304514
- Outcome
- Generally a chronic congenital condition with variable developmental impact; exact outcomes are not established.
- Factors
- Deletion extent, associated anomalies, developmental support, and comorbidities may influence course.
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
- Outcome
- Often chronic but potentially stable between crises when recognized and managed; severity varies.
- Factors
- Crisis frequency, trigger avoidance, dietary management, and neurologic complications may affect outcome.
Time frame: Lifelong for both, with metabolic risk often recognized in early childhood.
Prognosis cannot be individualized without clinical records and specialist evaluation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Developmental delay is a central reported feature, with variable severity. Neurologic effects may follow severe metabolic episodes, but outcomes vary. Neither course nor degree can be predicted from the supplied data alone. |
| Metabolic crisis | Not characteristic in the supplied description. Acid accumulation can cause acute illness requiring urgent care. Exact laboratory thresholds and mortality are not established here. |
| Long-term medical complexity | May involve ongoing developmental and congenital-feature management. Often centers on diet, avoidance of triggers, and crisis planning. Individual needs require specialist assessment. |
Patient education highlights
- HighDifferent causes
One condition is a chromosomal deletion; the other is a rare metabolic enzyme deficiency. Neither is contagious.
- HighUrgent warning signs
For the metabolic disorder, vomiting, lethargy, breathing changes, or reduced alertness during illness need urgent clinical advice.
- MediumTesting limits
An abnormal laboratory result is not automatically a diagnosis and should be interpreted by a clinician.